Heterogeneity of expression of the calcium-binding protein calretinin in human colonie cancer cell lines

Anticancer Research

Volumn 16, Issue 6 B, 1996, Pages 3491-3498

  Gotzos, V ^a   Schwaller, B ^a   Gander, J Ch ^a   Bustos Castillo, M ^a   Celio, M R ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Biochemistry; Calretinin; Histochemistry; Human colonic adenocarcinoma; In vitro study

Indexed keywords

CALCIUM BINDING PROTEIN; CALRETININ;

ARTICLE; CANCER CELL CULTURE; CELL DIVISION; CELL PROLIFERATION; COLON ADENOCARCINOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; BLOTTING, WESTERN; CACO-2 CELLS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; COLONIC NEOPLASMS; HUMANS; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0030514213     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Andressen C, Bliimcke I and Celio MR: Calcium-binding proteins: selective markers of nerve cells. Cell Tissue Res 271: 181-208, 1993.
2. Resibois A and Rogers JH: Calretinin in rat brain: An immunohistochemical study. Neuroscience 46: 101-134, 1992.
3. Rogers JH: Calretinin: A gene for a novel calcium-binding protein expressed principally in neurons. J Cell Biol 105: 1343- 1353, 1987.
4. Kiraly E, Gotzos V and Celio MR: In vitro detection of calretinin immunoreactivity in chicken embryo dorsal root ganglion neurons: a possible development.II marker. Develop Brain Res 76: 260-263, 1993.
5. Pohl V, Rampelbergh JV, Mellaert S, Parmentier M and Pochet R: Calretinin in rat ovary: an in situ hybridization and immunohistochemical study. Biochim et Biophys Acta 1160: 87-94, 1992.
6. Strauss KI, Isaacs KR, Ha QN and Jacobowitz DM: Calretinin is expressed in the Leydig cells of rat testis. Biochim et Biophys Acta 1219: 435-440, 1994.
7. Gotzos V, Schwaller B, Hetzel N, Bustos-Castillo M and Celio MR: Expression of the Calcium Binding Protein Calretinin in WiDr Cells and its Correlation to their Cell Cycle. Exp Cell Res 202: 292-302, 1992.
8. Forgue-Laffite ME, Rosselin G, Laburthe M, Cezard JP and Moody AJ: Peptidic regulation of gut epithelium: relationship with specific receptors in normal and cancerous cells. In: Colonic carcinogenesis (Malt RA and R Williamson RCN, eds.) MTP: Lancaster, 1982, pp. 339-352.
9. Cezard JP, Forgue-Laffite ME, Chamblier MC and Rosselin GE: Growth-promoting effect, biological activity and binding of insulin in human instestinal cancer cells in culture. Cancer Res 41: 1148-1153, 1981.
10. Zweibaum A, Laburthe M, Grasset E and Louvard D: Use of cultured cell lines in studies of intestinal cell differentiation and function. In: Handbook of physiology the gastrointestinal system. Alimentary canal. Intestinal absorption and secretion.(Rauner BB, ed.) Am Physiol Soc: Bethesda, MD, 1991, pp. 223-255.
11. Ametani A, Hachimura S, Yamamoto Y, Shimizu M, Imaoka A, Yi H-K, Hashimoto K, Kaminogawa S: Consecutive events of growth, differentiation and death of the small intestinal epithelial cell line, IEC-6. In vitro Cell Dev Biol Animal 32: 127-130, 1996.
12. Van Belzen N, Diesveld MPG, Vall der Made CJ, Nozawa Y, Dinjens WNM, Vliestra R, Trapman J, and Bosman F: Identification of mRNAs that show modulated expression during colon carcinoma cell differentiation. J Biochem 234: 843-848, 1995.
13. Fearon ER: Genetic alterations underlaying colorectal tumorigenesis. Cancer Surveys 12: 119-136, 1992.
14. Brattain MG, Fine WD, Khaled FM, Thompson J and Brattain DE: Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res 41: 1751-1756, 1981.
15. Boyd DD, Levine AF, Brattain DF, McKnight MK and Brattain MG: Comparison of growth requirements of two human intratumoral colon carcinoma cell lines in monolayer and soft agarose. Cancer Res 48: 2469-2474, 1988.
16. Cajot J, Kruithof EKO, Schleuning W-D, Sordat B and Bachmann F: Plasminogen activators, plasminogcn activators inhibitors and procoagulant analyzed in twenty human tumor cell lines. Int J Cancer 38: 719-727, 1986.
17. Trainer DL, Kline T, Mccabe FL, Faucette LF, Feild J, Chaikin M, Anzano M, Rieman D, Hoffstewin S, Li DJ, Gennaro D, Buscarino C, et al: Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int J Cancer 41: 287-296, 1988.
18. Hepler PK: The role of calcium in cell division. Cell Calcium 16: 322-330, 1994.
19. Schwaller B, Buchwald P, Blumcke I, Celio MR and Hunziker W: Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein Calretinin. Cell Calcium 14: 639-648, 1993.
20. Heizmann CW and Celio MR: Immunolocalization of parvalbumin. In: Methods in Enzymology (Means AR and Conn RM, eds). Vol. 139. 1987. New Yol-k: Academic Press, 1987, pp 552- 570.
21. Wasserman RH and Taylor AN: Vitamin D3-induced calcium binding protein in chick intestinal mucosa. Science 152: 791-793, 1966.
22. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem 162: 156-159, 1987.
23. Schwaller B, Celio MR and Hunziker W: Alternative splicing of calretinin mRNA leads to different forms of calretinin. Eur J Bioch 230: 424-430, 1995.
24. Parmentier M and Lefort A: Structure of the human brain calcium-binding protein calretinin and its expression in bacteria. Eur J Bioch 196: 79-85, 1991.
25. Couturier D, Couturier-Turpin M-H and Grandjouan S: Cancerogenese et cytogenetique. Gastraenterol. Clin Biol 7: 877-893, 1983.
26. Gander J-C, Gotzos V, Fellay B and Schwaller B: Inhibition of the proliferative cycle and apoptotic events in WiDr cells after down-regulation of the calcium-binding protein calretinin using antisense oligodeoxynucleotides. Exp Cell Res 225: 399-410, 1996.
27. Dowd DR, MacDonald PN, Komm BS, Haussler MR and Miesfeld RL: Stable expression of the calbindin-D28k complementary DNA interferes with the apoptotic pathway in lymphocytes. Mol Endo 6: 1843- 1848, 1992.
28. Tanaka K, Oshimura M, Kikuchi R, Seki M, Hayashi T and Miyaki M: Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18. Nature 349: 340-342, 1991.
29. Parsons R, Li G-M, Longley MJ, Fang W-H, Papadoupoulos N, Jen J, de la Chapelle A, Kinzler KW, Vogelstein B and Modrich P: Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75: 1227-1236, 1993.